Civik Thomas — SEC insider filings

SEC reporting owner CIK 1723092. 17 insider filings on record with FilingPulse; latest filed 2026-09-08.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2021-04-13 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Repare Therapeutics Inc. (RPTX)Director61 leg · 7,500 sh · $210,600—5
Pyxis Oncology, Inc. (PYXS)CEO & Chairman of the Board, Director91 leg · 15,700 sh · $200,018—8
FIVE PRIME THERAPEUTICS, INC. (FPRX)President and CEO, Director2——3

Insider filings — Civik Thomas

FiledFormIssuerReported transactionsSource
2026-09-084Pyxis Oncology, Inc. (PYXS)Grant/award (A): 2,503,050 (derivative) @ $0EDGAR
2026-08-144Pyxis Oncology, Inc. (PYXS)Grant/award (A): 250,956 (derivative) @ $0EDGAR
2026-02-054Pyxis Oncology, Inc. (PYXS)Grant/award (A): 690,131 (derivative) @ $0EDGAR
2026-01-284Repare Therapeutics Inc. (RPTX)Disposition to issuer (D): 7,500EDGAR
2025-04-024Pyxis Oncology, Inc. (PYXS)Grant/award (A): 36,979 (derivative) @ $0.98EDGAR
2024-06-204Repare Therapeutics Inc. (RPTX)Grant/award (A): 27,200 (derivative) @ $0EDGAR
2024-03-284Pyxis Oncology, Inc. (PYXS)Grant/award (A): 44,024 (derivative) @ $3.83EDGAR
2023-06-124Repare Therapeutics Inc. (RPTX)Grant/award (A): 27,200 (derivative) @ $0EDGAR
2023-03-284Pyxis Oncology, Inc. (PYXS)Grant/award (A): 139,355 @ $0EDGAR
2022-05-164Repare Therapeutics Inc. (RPTX)Grant/award (A): 49,000 (derivative) @ $0EDGAR
2022-04-044Pyxis Oncology, Inc. (PYXS)Grant/award (A): 66,831 @ $0EDGAR
2021-11-194Pyxis Oncology, Inc. (PYXS)Purchase (P): 15,700 @ $12.74EDGAR
2021-11-184Repare Therapeutics Inc. (RPTX)Purchase (P): 7,500 @ $28.08EDGAR
2021-10-124Pyxis Oncology, Inc. (PYXS)Grant/award (A): 42,191 (derivative) @ $0EDGAR
2021-09-094Repare Therapeutics Inc. (RPTX)Grant/award (A): 42,000 (derivative) @ $0EDGAR
2021-04-194FIVE PRIME THERAPEUTICS, INC. (FPRX)Disposition to issuer (D): 68,971 @ $38 · Disposition to issuer (D): 480,000 (derivative)EDGAR
2021-04-134FIVE PRIME THERAPEUTICS, INC. (FPRX)Tax withholding (F): 11,088 @ $37.94EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1723092 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs